This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Scripps Korea Antibody Institute. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Mee Hyun Jeoung: Innovator in Antibody Development
Introduction
Mee Hyun Jeoung is a notable inventor based in Gangwon-do, South Korea. His significant contributions to the field of biomedicine have led to the development of innovative antibodies, specifically targeting cancer treatment and angiogenesis suppression. With a focus on enhancing therapeutic solutions, Jeoung has made strides in the medical research community.
Latest Patents
Jeoung holds a patent for an "Antibody specific for CLEC14A and uses thereof." This patent details an antibody that binds specifically to the CTLD (C-type lectin-like domain) of clec14a. The applications of this invention are extensive, as it includes methods for preparing the antibody and compositions aimed at suppressing angiogenesis, preventing or treating cancer, and diagnosing cancer. This innovation showcases the potential for tailored cancer therapies utilizing the unique properties of the clec14a protein.
Career Highlights
Mee Hyun Jeoung is currently associated with the Scripps Korea Antibody Institute, where he plays a pivotal role in advancing research in antibody development. His work is characterized by a commitment to understanding complex biological mechanisms and translating this knowledge into viable medical applications. With one patent to his name, he has established a foundation for further innovations in the field.
Collaborations
Throughout his career, Jeoung has collaborated with esteemed colleagues, including Suk Mook Lee and Min Kyoung Ki. These partnerships have enhanced the research environment at the Scripps Korea Antibody Institute, fostering a culture of innovation and scientific exploration that drives the development of groundbreaking therapies.
Conclusion
Mee Hyun Jeoung continues to be an influential figure in the field of biomedicine, with his work on antibodies serving as a testament to the power of innovation in healthcare. As he advances his research and collaborates with other talented professionals, the impact of his inventions on cancer treatment and angiogenesis suppression is poised to grow, offering hope for improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile